Although substantial weight loss can reduce pathological joint loading and systemic inflammation, the direct pharmacological effects on synovial fibroblastsattenuating their inflammatory signalling and fibrotic activation may offer an additional, disease-modifying and analgesic mechanism that targets the local synovial environment, driving pain and structural progression
Your healthcare provider can advise you best on timelines based on your unique situation. If you're considering semaglutide or currently using it, focus on maintaining excellent nutrition, managing stress, and working closely with your healthcare provider who understands both the benefits and potential side effects
As more patients use GLP-1 medications such as semaglutide and tirzepatide, clinicians are starting to ask an important question: are these drugs quietly contributing to the Read More Fragmented Care in the GLP-1 Era: What Happens When Multiple Providers Prescribe the Same Therapy
Menopause is associated with accelerated age-related weight gain and a higher likelihood of developing overweight or obesity, both of which are major risk factors for cardiovascular disease, type 2 diabetes, and other long-term conditions
This pairing is not about adding more nutrients
Two weeks before PTSD modeling, we co-injected a GFAP-Cre-mCherry with pSico-scrambled (Sc) short hairpin RNA (shRNA) or MAOB shRNA (shMAOB) into the IL cortex, generating the Sc+PTSD and shMAOB+PTSD groups, respectively (Fig
